Intended for healthcare professionals

Education And Debate

Marketing medicines through randomised controlled trials: the case of interferon

BMJ 1998; 317 doi: https://doi.org/10.1136/bmj.317.7167.1231 (Published 31 October 1998) Cite this as: BMJ 1998;317:1231